CRVS
Corvus Pharmaceuticals
$12.92
−$0.15 (−1.15%)Jul 27, 2026
Key metrics
The numbers that frame CRVS today
- Market cap
- $1.09B
- P/E (TTM)
- -24.6
- EV / FCF
- -29.8
- ROIC
- -44.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.96
- 52wk High
- $26.95
Growth
Revenue and earnings trend for CRVS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRVS
Is Corvus Pharmaceuticals a good buy?
Hold. Corvus Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Corvus Pharmaceuticals is selling at a high price.
What is the market capitalization of CRVS?
Corvus Pharmaceuticals's market capitalization is $1.09B.
What is the P/E ratio for CRVS stock?
Corvus Pharmaceuticals's current P/E ratio is -24.6.
What is the 52-week high for CRVS stock?
The 52-week high for Corvus Pharmaceuticals is $26.95. The current close of $12.92 is 52.1% below that high.
What is the 52-week low for CRVS stock?
The 52-week low for Corvus Pharmaceuticals is $3.96. The current close of $12.92 is 226.3% above that low.
Does CRVS stock pay dividends?
Corvus Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRVS?
Corvus Pharmaceuticals's Debt / Equity ratio is 0.